Login / Signup

Stakeholders' views on priorities essential for establishing a supportive environment for clinical trials in nursing homes.

Christopher DeludeIvan H Abi-EliasCharlene Connolly QuinnAlyce S AdamsJay S MagazinerKouta ItoPaavani JainJerry H GurwitzKathleen M Mazor
Published in: Journal of the American Geriatrics Society (2022)
Developing a robust U.S. clinical research enterprise capable of efficiently mounting future clinical trials in nursing homes will require a reimagining of the relationships that exist between researchers, facilities, nursing home leaders, and residents, with a research infrastructure specifically focused on supporting and fostering these connections.
Keyphrases
  • clinical trial
  • phase ii
  • open label
  • current status
  • phase iii
  • double blind
  • study protocol
  • randomized controlled trial